IJHSR

International Journal of Health Sciences and Research

| Home | Current Issue | Archive | Instructions to Authors |

Year: 2025 | Month: December | Volume: 15 | Issue: 12 | Pages: 159-166

DOI: https://doi.org/10.52403/ijhsr.20251221

Comparative Study of Functional and Radiological Outcome of Closed Intertrochanteric Fracture Femur Managed by PFN and PFNA2

Dr. Soumyadeep Pandit1, Dr. Lakhan Singh Maravi2, Dr. Sparsh Naik3

1Post Graduate Student, Department of Orthopaedics Netaji Subhash Chandra Bose Medical College, Jabalpur (M. P.)
2Professor and Head, Department of Orthopaedics Netaji Subhash Chandra Bose Medical College, Jabalpur (M. P.)
3Assistant Professor, Department of Orthopaedics Netaji Subhash Chandra Bose Medical College, Jabalpur (M. P.)

Corresponding Author: Dr. Lakhan Singh Maravi

ABSTRACT

Background: Intertrochanteric fractures occur in the proximal femur extending from the extracapsular basilar neck region to the region along the lower border lesser trochanter. Intramedullary fixation with Cephalomedullary nail (CMN) is the current gold standard for managing intertrochanteric fractures. This study aims to compare functional and radiological outcome of intertrochanteric fracture managed by Proximal Femoral Nail (PFN) and Proximal Femoral Nail Antirotation for Asian Population (PFNA2).
Methodology: This prospective study was conducted on 50 patients with intertrochanteric femur fractures, among them 25 patients were managed by PFN and 25 patients were managed by PFNA2 at N.S.C.B. Medical College, Jabalpur, between April 2023 and March 2025. Patients were followed up at 1, 3, and 6 months postoperatively for clinical and radiological assessment, using the Harris Hip Score (HHS).
Results: Of the 50 patients enrolled, 48 patients had a complete follow up of 6 months postoperatively. Majority of patients were in age group of 61-70 years in both PFN and PFNA2 group. Mean duration of surgery for PFN was 90.28±8.28 min and for PFNA2 was 72.40±6.31 min and mean amount of blood loss in PFN was 125.4±9.23 ml and in PFNA2 was 98.4±8.26 ml. Differences between average HHS of PFN and PFNA2 group after 1 month, 3 months and 6 months are statistically significant.
Conclusion: PFNA2 has emerged as a superior implant for management of intertrochanteric femur fractures. It offers better functional outcome and fewer complications compared to PFN.

Key words: Intertrochanteric femur fracture, CMN, PFN, PFNA2, HHS

[PDF Full Text]